Distinguished Australian scientist Emeritus Professor Ian Frazer AC to deliver Millis Oration at AusBiotech 2023 national conference in Brisbane.
As the 2023 Millis Orator, Prof. Frazer, Frazer Institute, University of Queensland; Director, Microba (ASX:MAP), will share his assessment of the sector’s current state and predictions for Australian biotechnology, and identify the challenges to address for Australia to develop more revolutionary health treatments while building our sovereign vaccine and drug manufacturing capabilities.
In the wake of a global pandemic, Australia’s immediate focus is on sovereign vaccine manufacturing capacity expansion. In broadening the nation’s agenda, it will require talent, and bolstered capacity along the entire bench to bedside pathway. This is necessary not only to ensure Australia’s future health, but also to contribute to our national prosperity.
With unwavering determination and endless passion, 2023’s Millis Orator Prof. Frazer will delve into what part of this agenda we meet currently, and what are the challenges that hinder our progress towards the rest, as Australia paves the way for more, revolutionary global health advancements.
The significant global impact of distinguished scientist Emeritus Professor Ian Frazer AC’s transformative research led to the Gardasil® vaccine, thereby crystallising him as a household name for Australian biotechnology and beyond.
Gaining FDA approval in 2006, Gardasil® set a relentless pace and dominated the global HPV vaccine market: it’s now available in more than 120 countries with more than 100 million doses having been distributed around the world.
The Millis Oration is named in honour of contribution to the industry, and is held annually at the , together with CSL. The Oration is a focal point of the annual industry gathering and is appropriately named in honour of this pioneer of Australia’s biotechnology industry.
Chaired by Dr Andrew Nash, Chief Scientific Officer, CSL, register today to hear the Millis Oration, and 100+ more leaders from across the sector at AusBiotech 2023, Australia’s largest life science conference. Delivered for industry, by industry, AusBiotech 2023 will take place in Brisbane on 1 – 3 November.
AusBiotech 2023 is created by industry, for industry; and for more than three decades it has created a forum to reflect on the sector’s achievements and exchange ideas to further advance the industry. This year’s programme features an all-day AgriBiotech Summit, the Early-Stage Innovation Forum, conference gala dinner, and an array of networking opportunities, both formal and informal.
AusBiotech 2023, is proudly sponsored by the Queensland Government. Register now for AusBiotech 2023 to celebrate and connect with our thriving Australian and global biotechnology network.
AusBiotech encourages delegates to take advantage of early-bird registrations before 18 September; .
